These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10999484)

  • 1. Design, synthesis, and discovery of 3-piperazinyl-3,4-dihydro-2(1H)-quinolinone derivatives: a novel series of mixed dopamine D2/D4 receptor antagonists.
    Zhao H; Thurkauf A; Braun J; Brodbeck R; Kieltyka A
    Bioorg Med Chem Lett; 2000 Sep; 10(18):2119-22. PubMed ID: 10999484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2,2-Dicyanovinyl as a nonaromatic aryl bioisostere: synthesis, binding experiments and SAR studies of highly selective dopamine D4 receptor ligands.
    Haubmann C; Hübner H; Gmeiner P
    Bioorg Med Chem Lett; 1999 Jul; 9(14):1969-72. PubMed ID: 10450964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone derivatives.
    Oshiro Y; Sato S; Kurahashi N; Tanaka T; Kikuchi T; Tottori K; Uwahodo Y; Nishi T
    J Med Chem; 1998 Feb; 41(5):658-67. PubMed ID: 9513593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,4-dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-3,4- dihydro-5-methoxy-2(1H)-quinolinone and its derivatives.
    Oshiro Y; Sakurai Y; Sato S; Kurahashi N; Tanaka T; Kikuchi T; Tottori K; Uwahodo Y; Miwa T; Nishi T
    J Med Chem; 2000 Jan; 43(2):177-89. PubMed ID: 10649973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and discovery of 5-piperazinyl-1,2,6,7-tetrahydro-5H-azepino[3,2,1-hi]indol-4-one derivatives: a novel series of mixed dopamine D2/D4 receptor antagonist.
    Zhao H; Zhang X; Hodgetts K; Thurkauf A; Hammer J; Chandrasekhar J; Kieltyka A; Brodbeck R; Rachwal S; Primus R; Manly C
    Bioorg Med Chem Lett; 2003 Feb; 13(4):701-4. PubMed ID: 12639562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications.
    Lahti RA; Evans DL; Stratman NC; Figur LM
    Eur J Pharmacol; 1993 Jun; 236(3):483-6. PubMed ID: 8102973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and dopamine D4 receptor binding activities of new N-heteroaromatic 5/6-ring Mannich bases.
    Linz S; Müller J; Hübner H; Gmeiner P; Troschütz R
    Bioorg Med Chem; 2009 Jul; 17(13):4448-58. PubMed ID: 19481941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and dual D2 and 5-HT1A receptor binding affinities of 5-piperidinyl and 5-piperazinyl-1H-benzo[d]imidazol-2(3H)-ones.
    Ullah N
    J Enzyme Inhib Med Chem; 2014 Apr; 29(2):281-91. PubMed ID: 23488743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the clozapine structure increases its selectivity for the dopamine D4 receptor.
    Liégeois JF; Bruhwyler J; Damas J; Rogister F; Masereel B; Geczy J; Delarge J
    Eur J Pharmacol; 1995 Feb; 273(3):R1-3. PubMed ID: 7737323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indoline and piperazine containing derivatives as a novel class of mixed D(2)/D(4) receptor antagonists. Part 2: asymmetric synthesis and biological evaluation.
    Zhao H; He X; Thurkauf A; Hoffman D; Kieltyka A; Brodbeck R; Primus R; Wasley JW
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3111-5. PubMed ID: 12372513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and evaluation of chromen-2-ones as potent and selective human dopamine D4 antagonists.
    Kesten SR; Heffner TG; Johnson SJ; Pugsley TA; Wright JL; Wise LD
    J Med Chem; 1999 Sep; 42(18):3718-25. PubMed ID: 10479303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on 2(1H)-quinolinone derivatives as neuroleptic agents I. Synthesis and biological activities of (4-phenyl-1-piperazinyl)-propoxy-2(1H)-quinolinone derivatives.
    Banno K; Fujioka T; Kikuchi T; Oshiro Y; Hiyama T; Nakagawa K
    Chem Pharm Bull (Tokyo); 1988 Nov; 36(11):4377-88. PubMed ID: 2907733
    [No Abstract]   [Full Text] [Related]  

  • 14. Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist.
    Burstein ES; Ma J; Wong S; Gao Y; Pham E; Knapp AE; Nash NR; Olsson R; Davis RE; Hacksell U; Weiner DM; Brann MR
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1278-87. PubMed ID: 16135699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substituted pyrazoles as novel selective ligands for the human dopamine D4 receptor.
    Bourrain S; Collins I; Neduvelil JG; Rowley M; Leeson PD; Patel S; Patel S; Emms F; Marwood R; Chapman KL; Fletcher AE; Showell GA
    Bioorg Med Chem; 1998 Oct; 6(10):1731-43. PubMed ID: 9839003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromeno[3,4-c]pyridin-5-ones: selective human dopamine D4 receptor antagonists as potential antipsychotic agents.
    Unangst PC; Capiris T; Connor DT; Heffner TG; MacKenzie RG; Miller SR; Pugsley TA; Wise LD
    J Med Chem; 1997 Aug; 40(17):2688-93. PubMed ID: 9276014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D2 and D4 receptor ligands: relation to antipsychotic action.
    Wilson JM; Sanyal S; Van Tol HH
    Eur J Pharmacol; 1998 Jun; 351(3):273-86. PubMed ID: 9721018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes.
    Lawler CP; Prioleau C; Lewis MM; Mak C; Jiang D; Schetz JA; Gonzalez AM; Sibley DR; Mailman RB
    Neuropsychopharmacology; 1999 Jun; 20(6):612-27. PubMed ID: 10327430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship studies of CNS agents. XII. 1-[4-(4-aryl-1-piperazinyl)butyl]-3,4-dihydro-2(1H)-quinolinones: new 5-HT1A, 5-HT2 and D2 ligands with a potential antipsychotic activity.
    Mokrosz JL; Chojnacka-Wójcik E; Dereń-Wesołek A; Kłodzińska A; Maćkowiak M; Bielecka Z; Paluchowska MH
    Drug Des Discov; 1994 Apr; 11(3):197-203. PubMed ID: 7548635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D4 receptors may alleviate antipsychotic-induced parkinsonism.
    Seeman P; Corbett R; Van Tol HH
    Adv Pharmacol; 1998; 42():478-82. PubMed ID: 9327943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.